Collection: Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80% while improving article selection accuracy by 37%. It ensures faster, more reliable safety signal detection without sacrificing oversight, helping manage the overwhelming flow of data to protect patient safety.
-
Safety Shield Study for VALACYCLOVIR
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for VANCOMYCIN
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for VARDENAFIL
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for VEMURAFENIB
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for VOCLOSPORIN
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for VORICONAZOLE
Regular price From β¬800,00 EURRegular priceUnit price / per -
Safety Shield Study for ZINC PYRITHIONE
Regular price From β¬800,00 EURRegular priceUnit price / per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...